• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Europe Insomnia Market

    ID: MRFR/Pharma/0151-HCR
    80 Pages
    Rahul Gotadki
    October 2025

    EMEA Insomnia Market Research Report Information By Types Of Therapy (Pharmacological Therapy and Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablets and Others), By Type Of Diseases Condition (Poor Quality Of Sleep, Sleep Maintenance and Other) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Europe Insomnia Market Infographic
    Purchase Options

    Europe Insomnia Market Summary

    The Europe EMEA Insomnia market is poised for substantial growth, projected to reach 2.09 USD Billion by 2035 from a base of 0.5 USD Billion in 2024.

    Key Market Trends & Highlights

    EMEA Insomnia Key Trends and Highlights

    • The Europe EMEA Insomnia market is valued at 0.5 USD Billion in 2024 and is expected to grow to 2.09 USD Billion by 2035.
    • The market is anticipated to experience a compound annual growth rate (CAGR) of 13.91% from 2025 to 2035.
    • Increasing awareness of sleep disorders is likely to drive market expansion, contributing to the overall growth.
    • Growing adoption of innovative sleep solutions due to rising health consciousness is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.5 (USD Billion)
    2035 Market Size 2.09 (USD Billion)
    CAGR (2025-2035) 13.91%

    Major Players

    Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK), CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)

    Market Segment Insights

    EMEA Insomnia Type Insights

    Europe, the Middle East and Africa insomnia market has been segmented on the basis of types of therapy which comprises pharmacological therapy and non-pharmacological therapy. Pharmacological therapy is further segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Non pharmacological treatment are further segmented into relaxation therapy, cognitive behavioural therapy, sleep hygiene education, stimulus control, paradoxical intention and other. 

    EMEA Insomnia Drug Formulation Insights

    By drug formulation they are segmented as capsules, tablet and others. 

    EMEA Insomnia Disease Insights

    On the basis of type of disease they are poor quality of sleep, sleep maintenance and other.

    Get more detailed insights about EMEA Insomnia Market Research Report- Europe, the Middle East and Africa Forecast till 2032

    Key Companies in the Europe Insomnia Market market include

    Report Scope

    Attribute/Metric Details
      Market Size   USD 1.9 Billion
      CAGR   3.3%
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data  2021
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Target Antigen, Application and Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors  Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland). Others players are  Flynn Pharma (UK) CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)
      Key Market Opportunities   Increase in the setups of research & development centers and the inclination of top companies toward the developing countries boost
      Key Market Drivers prevalence of cancers is increasing the demand for effective treatment The growth of the obese population

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials